VT News
Carlos PenaVega

Carlos PenaVega

Ask VT AI
View News Summary
  • Kenvue, the maker of Tylenol, is fighting to prevent the FDA from adding an autism warning to the drug's label, citing lack of scientific evidence.
  • Ofgem unveils a £500 million energy debt write-off scheme to help struggling households, raising concerns over potential cost socialisation.
  • NYC early voting surges as mayoral race intensifies, with candidates focusing on affordability and public safety.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Kenvue, the maker of Tylenol, is fighting to prevent the FDA from adding an autism warning to the drug's label, citing lack of scientific evidence.
  • Ofgem unveils a £500 million energy debt write-off scheme to help struggling households, raising concerns over potential cost socialisation.
  • NYC early voting surges as mayoral race intensifies, with candidates focusing on affordability and public safety.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Carlos PenaVega

Top Topics

Trending in U.S.

World

Sport